1. Korf, B. Neurofibromas and Malignant Tumors of the Peripheral Nervous System. In Neurofibromatosis: Phe-notype, Natural History, and Phatogenesis, Third Edition; Friedman, J.M., Gutmann, D.H., MacCollin, M., Riccardi, V.M., Eds.; Johns Hopkins: Baltimore, 1999; 142-161.

2. Korf, B.R. Diagnostic outcome in children with multiple cafe au lait spots. Pediatrics 1992, 90 (6), 924-927.

3. Lubs, M.-L.E.; Bauer, M.S.; Formas, M.E.; Djokic, B. Lisch nodules in neurofibromatosis type 1. N. Engl. J. Med. 1991, 324, 1264-1266.

4. Crawford, A.H.; Schorry, E.K. Neurofibromatosis in children: The role of the orthopaedist. J. Am. Acad. Orthop. Surg. 1999, 7 (4), 217 -230.

5. Szudek, J.; Birch, P.; Friedman, J.M. Growth charts for young children with neurofibromatosis 1 (NF1). Am. J. Med. Genet. 2000, 92 (3), 224-228.

6. Friedman, J.M.; Arbiser, J.; Epstein, J.A.; Gutmann, D.H.; Huot, S.J.; Lin, A.E.; McManus, B.; Korf, B.R. Cardiovascular disease in neurofibromatosis 1: Report of the NF1 Cardiovascular Task Force. Genet. Med. 2002, 4 (3), 105-111.

7. North, K.N.; Riccardi, V.; Samango-Sprouse, C.; Ferner, R.; Moore, B.; Legius, E.; et al. Cognitive function and academic performance in neurofibromatosis 1: Consensus statement from the NF1 cognitive disorders task force. Neurology 1997, 48 (4), 1121-1127.

8. Korf, B.R. Malignancy in neurofibromatosis type 1. Oncologist 2000, 5 (6), 477-485.

9. Listernick, R.; Louis, D.N.; Packer, R.J.; Gutmann, D.H. Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann. Neurol. 1997, 41 (2), 143-149.

10. Gutmann, D.H.; Aylsworth, A.; Carey, J.C.; Korf, B.; Marks, J.; Pyeritz, R.E.; et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997, 278 (1), 51-57.

11. Rasmussen, S.A.; Yang, Q.; Friedman, J. Mortality in neurofibromatosis 1: An analysis using U.S. death certificates. Am. J. Hum. Genet. 2001, 68, 1110-1118.

12. Cichowski, K.; Jacks, T. NF1 tumor suppressor gene function: Narrowing the GAP. Cell 2001, 104 (4), 593604.

13. Messiaen, L.M.; Callens, T.; Mortier, G.; Beysen, D.; Vandenbroucke, I.; Van Roy, N.; et al. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects. Human Mutat. 2000, 15 (6), 541-555.

14. Leppig, K.A.; Kaplan, P.; Viskochil, D.; Weaver, M.; Ortenberg, J.; Stephens, K. Familial neurofibromatosis 1 microdeletions: Cosegregation with distinct facial pheno-type and early onset of cutaneous neurofibromata. Am. J. Med. Genet. 1997, 73 (2), 197 -204.

Was this article helpful?

0 0
Peripheral Neuropathy Natural Treatment Options

Peripheral Neuropathy Natural Treatment Options

This guide will help millions of people understand this condition so that they can take control of their lives and make informed decisions. The ebook covers information on a vast number of different types of neuropathy. In addition, it will be a useful resource for their families, caregivers, and health care providers.

Get My Free Ebook

Post a comment